Philippe Bouhours

619 total citations
20 papers, 481 citations indexed

About

Philippe Bouhours is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Philippe Bouhours has authored 20 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Cognitive Neuroscience. Recurrent topics in Philippe Bouhours's work include Schizophrenia research and treatment (8 papers), Treatment of Major Depression (4 papers) and Epilepsy research and treatment (3 papers). Philippe Bouhours is often cited by papers focused on Schizophrenia research and treatment (8 papers), Treatment of Major Depression (4 papers) and Epilepsy research and treatment (3 papers). Philippe Bouhours collaborates with scholars based in France, Belgium and United States. Philippe Bouhours's co-authors include J.-M. Azorin, Olivier Blin, Robert Lasser, Cynthia A. Bossie, Georges M. Gharabawi, Martin B. Keller, Carla M. Canuso, Fiona Dunbar, Mark Hyman Rapaport and Ibrahim Turkoz and has published in prestigious journals such as Neuropsychopharmacology, Psychopharmacology and Epilepsia.

In The Last Decade

Philippe Bouhours

20 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Bouhours France 11 329 131 88 75 74 20 481
Dennis Sweitzer United States 11 672 2.0× 196 1.5× 102 1.2× 37 0.5× 50 0.7× 13 833
Pedro Such Denmark 11 307 0.9× 135 1.0× 40 0.5× 30 0.4× 64 0.9× 32 486
A. Labelle Canada 3 623 1.9× 130 1.0× 181 2.1× 124 1.7× 36 0.5× 3 785
Michel Patris France 7 355 1.1× 190 1.5× 85 1.0× 26 0.3× 63 0.9× 15 425
Richard M. Steinbook United States 12 346 1.1× 87 0.7× 84 1.0× 70 0.9× 90 1.2× 26 543
Umberto Micò Italy 13 347 1.1× 100 0.8× 61 0.7× 93 1.2× 83 1.1× 21 584
S. Heylen Belgium 7 452 1.4× 97 0.7× 96 1.1× 99 1.3× 21 0.3× 11 560
Joseph Pultz United States 8 296 0.9× 85 0.6× 47 0.5× 57 0.8× 36 0.5× 11 526
G. Remington Canada 8 468 1.4× 78 0.6× 74 0.8× 91 1.2× 33 0.4× 8 712
O. Fleurot France 8 715 2.2× 256 2.0× 146 1.7× 45 0.6× 106 1.4× 22 797

Countries citing papers authored by Philippe Bouhours

Since Specialization
Citations

This map shows the geographic impact of Philippe Bouhours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Bouhours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Bouhours more than expected).

Fields of papers citing papers by Philippe Bouhours

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Bouhours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Bouhours. The network helps show where Philippe Bouhours may publish in the future.

Co-authorship network of co-authors of Philippe Bouhours

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Bouhours. A scholar is included among the top collaborators of Philippe Bouhours based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Bouhours. Philippe Bouhours is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krebs, Marie‐Odile, Marie‐Chantal Bourdel, Philippe Bouhours, et al.. (2010). Deficit of inhibition motor control in untreated patients with schizophrenia: Further support from visually guided saccade paradigms. Psychiatry Research. 179(3). 279–284. 13 indexed citations
2.
Amado, I., M.-C. Bourdel, Claire Daban, et al.. (2009). Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(7). 1107–1112. 9 indexed citations
3.
Llorca, PM, et al.. (2008). Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone. L Encéphale. 34(2). 170–178. 14 indexed citations
4.
Bordet, Régis, Pierre Lestage, Philippe Bouhours, et al.. (2007). Neuroprotection: Present and future. Therapies. 62(6). 473–476. 2 indexed citations
5.
Bordet, Régis, Pierre Lestage, Philippe Bouhours, et al.. (2007). Des agents neuroprotecteurs au concept de traitement modulateur du cours évolutif des maladies cérébrales. Therapies. 62(6). 463–472. 1 indexed citations
6.
Docherty, John P., Cynthia A. Bossie, B. Lachaux, et al.. (2007). Patient-based and clinician-based support for the remission criteria in schizophrenia.. PubMed. 22(1). 51–5. 27 indexed citations
7.
Rapaport, Mark Hyman, Georges M. Gharabawi, Carla M. Canuso, et al.. (2006). Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation. Neuropsychopharmacology. 31(11). 2505–2513. 104 indexed citations
8.
Llorca, Pierre‐Michel, et al.. (2006). Symptom control, functioning, and hospitalization status in French patients changed from oral atypical antipsychotics to risperidone long-acting injectable. International Journal of Psychiatry in Clinical Practice. 10(4). 276–284. 6 indexed citations
9.
Gharabawi, Georges M., Cynthia A. Bossie, Philippe Bouhours, Ibrahim Turkoz, & M. Kujawa. (2006). P.3.a.048 Insight in schizophrenia: clinical correlates and relationship to functioning. European Neuropsychopharmacology. 16. S390–S391. 1 indexed citations
10.
Mannaert, Erik, An Vermeulen, Bart Remmerie, Philippe Bouhours, & J. C. Levron. (2005). Pharmacokinetic profile of long-acting injectable risperidone at steady-state : comparison with oral administration. L Encéphale. 31(5). 609–615. 26 indexed citations
11.
Kissling, Werner, Stephan Heres, Keith Lloyd, et al.. (2005). Direct transition to long-acting risperidone - analysis of long-term efficacy. Journal of Psychopharmacology. 19(5_suppl). 15–21. 50 indexed citations
12.
13.
Mikaeloff, Yann, Elisabeth Rey, Christine Soufflet, et al.. (2004). Topiramate Pharmacokinetics in Children with Epilepsy Aged from 6 Months to 4 Years. Epilepsia. 45(11). 1448–1452. 27 indexed citations
14.
Bouhours, Philippe, et al.. (2003). Attractivité de la France pour les essais cliniques : évaluation par les laboratoires promoteurs. Therapies. 58(3). 283–289. 10 indexed citations
15.
Allain, H., et al.. (2003). Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology. 165(4). 419–429. 24 indexed citations
16.
Viola, Antoine, et al.. (2002). Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers. Clinical Neurophysiology. 113(3). 429–434. 33 indexed citations
17.
Pageaux, Georges‐Philippe, et al.. (2001). Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers. British Journal of Clinical Pharmacology. 51(2). 164–168. 2 indexed citations
18.
Blin, Olivier, J.-M. Azorin, & Philippe Bouhours. (1996). Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic Patients. Journal of Clinical Psychopharmacology. 16(1). 38–44. 98 indexed citations
19.
Danjou, P., D. Warot, T. Hergueta, et al.. (1992). Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses. International Clinical Psychopharmacology. 7(2). 73–79. 23 indexed citations
20.
Rémond, A & Philippe Bouhours. (1988). Memoire, attention, potentiels evoques au cours du vieillissement et dans la demence senile de type Alzheimer. Neurophysiologie Clinique. 18(2). 153–160. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Sweitzer Breakdown of academic impact, for papers by Pedro Such Breakdown of academic impact, for papers by A. Labelle Breakdown of academic impact, for papers by Michel Patris Breakdown of academic impact, for papers by Richard M. Steinbook Breakdown of academic impact, for papers by Umberto Micò Breakdown of academic impact, for papers by S. Heylen Breakdown of academic impact, for papers by Joseph Pultz Breakdown of academic impact, for papers by G. Remington Breakdown of academic impact, for papers by O. Fleurot
Rankless by CCL
2026